Abnormal myocardial function is related to myocardial steatosis and diffuse myocardial fibrosis in HIV-infected adults

Diana K. Thiara, Chia Ying Liu, Fabio Raman, Sabrina Mangat, Julia B. Purdy, Horacio A. Duarte, Nancyanne Schmidt, Jamie Hur, Christopher T. Sibley, David A. Bluemke, Colleen Hadigan

Research output: Contribution to journalArticle

48 Scopus citations

Abstract

Background. Impaired cardiac function persists in the era of effective human immunodeficiency virus (HIV) therapy, although the etiology is unclear. We used magnetic resonance imaging (MRI) to measure intramyocardial lipid levels and fibrosis as possible contributors to HIV-associated myocardial dysfunction. Methods. A cross-sectional study of 95 HIV-infected and 30 matched-healthy adults, without known cardiovascular disease (CVD) was completed. Intramyocardial lipid levels, myocardial fibrosis, and cardiac function (measured on the basis of strain) were quantified by MRI. Results. Systolic function was significantly decreased in HIV-infected subjects as compared to controls (mean radial strain [±SD], 21.7 ± 8.6% vs 30.5 ± 14.2%; P = .004). Intramyocardial lipid level and fibrosis index were both increased in HIV-infected subjects as compared to controls (P ≤ .04 for both) and correlated with the degree of myocardial dysfunction measured by strain parameters. Intramyocardial lipid levels correlated positively with antiretroviral therapy duration and visceral adiposity. Further, impaired myocardial function was strongly correlated with increased monocyte chemoattractant protein 1 levels (r = 0.396, P = .0002) and lipopolysaccharide binding protein levels (r = 0.25, P = .02). Conclusions. HIV-infected adults have reduced myocardial function as compared to controls in the absence of known CVD. Decreased cardiac function was associated with abnormal myocardial tissue composition characterized by increased lipid levels and diffuse myocardial fibrosis. Metabolic alterations related to antiretroviral therapy and chronic inflammation may be important targets for optimizing long-term cardiovascular health in HIV-infected individuals.

Original languageEnglish (US)
Pages (from-to)1544-1551
Number of pages8
JournalJournal of Infectious Diseases
Volume212
Issue number10
DOIs
StatePublished - Jan 1 2015

    Fingerprint

Keywords

  • Antiretroviral therapy
  • HIV
  • Intramyocardial lipid
  • Magnetic resonance spectroscopy
  • Myocardial strain

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Thiara, D. K., Liu, C. Y., Raman, F., Mangat, S., Purdy, J. B., Duarte, H. A., Schmidt, N., Hur, J., Sibley, C. T., Bluemke, D. A., & Hadigan, C. (2015). Abnormal myocardial function is related to myocardial steatosis and diffuse myocardial fibrosis in HIV-infected adults. Journal of Infectious Diseases, 212(10), 1544-1551. https://doi.org/10.1093/infdis/jiv274